Clinical and economic analysis of the use of apixaban for the treatment of venous thromboembolic events
Aim. Pharmacoeconomic analysis of apixaban use compared to conventional therapy in patients with venous thromboembolism (VTE).Material and methods. Economic evaluation was performed from a position of the health care system. The cost analysis, "cost-effectiveness" analysis, "impact on...
Saved in:
| Main Author: | O. V. Shatalova |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2015-12-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/439 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EFFICACY AND SAFETY OF THE ORAL ANTICOAGULANTS IN THE MANAGEMENT OF VENOUS THROMBOEMBOLISM: INDIRECT COMPARISON
by: V. I. Petrov, et al.
Published: (2016-12-01) -
Effect of drug interactions with apixaban on clinical outcomes in cancer patients with venous thromboembolism
by: Marte Svalastoga, et al.
Published: (2025-01-01) -
Cost-effectiveness analysis of apixaban compared to low-molecularweight heparins and vitamin k antagonists for treatment and secondary prevention of venous thromboembolism
by: Isabel Elías, et al.
Published: (2016-05-01) -
Hospitalizations for bleeding associated with apixaban versus rivaroxaban according to dose in Medicare beneficiaries
by: Luke S. Vest, et al.
Published: (2025-09-01) -
Venous thromboembolic complications
by: G. G. Khubulava, et al.
Published: (2019-02-01)